• Something wrong with this record ?

Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases

M. Česnek, D. Hocková, A. Holý, M. Dračínský, O. Baszczyňski, Jd. Jersey, DT. Keough, LW. Guddat,

. 2012 ; 20 (2) : 1076-89.

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

The purine salvage enzyme, hypoxanthine-guanine-(xanthine) phosphoribosyltransferase [HG(X)PRT], catalyses the synthesis of the purine nucleoside monophosphates, IMP, GMP or XMP essential for DNA/RNA production. In protozoan parasites, such as Plasmodium, this is the only route available for their synthesis as they lack the de novo pathway which is present in human cells. Acyclic nucleoside phosphonates (ANPs), analogs of the purine nucleoside monophosphates, have been found to inhibit Plasmodium falciparum (Pf) HGXPRT and Plasmodium vivax (Pv) HGPRT with K(i) values as low as 100 nM. They arrest parasitemia in cell based assays with IC(50) values of the order of 1-10 μM. ANPs with phosphonoalkyl and phosphonoalkoxyalkyl moieties linking the purine base and phosphonate group were designed and synthesised to evaluate the influence of this linker on the potency and/or selectivity of the ANPs for the human and malarial enzymes. This data shows that variability in the linker, as well as the positioning of the oxygen in this linker, influences binding. The human enzyme binds the ANPs with K(i) values of 0.5 μM when the number of atoms in the linker was 5 or 6 atoms. However, the parasite enzymes have little affinity for such long chains unless oxygen is included in the three-position. In comparison, all three enzymes have little affinity for ANPs where the number of atoms linking the base and the phosphonate group is of the order of 2-3 atoms. The chemical nature of the purine base also effects the K(i) values. This data shows that both the linker and the purine base play an important role in the binding of the ANPs to these three enzymes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12024175
003      
CZ-PrNML
005      
20121206115322.0
007      
ta
008      
120815s2012 enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.bmc.2011.11.034 $2 doi
035    __
$a (PubMed)22178188
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Česnek, Michal $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of Czech Republic, Flemingovo nam. 2, 166 10 Prague 6, Czech Republic. cesnekm@uochb.cas.cz
245    10
$a Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases / $c M. Česnek, D. Hocková, A. Holý, M. Dračínský, O. Baszczyňski, Jd. Jersey, DT. Keough, LW. Guddat,
520    9_
$a The purine salvage enzyme, hypoxanthine-guanine-(xanthine) phosphoribosyltransferase [HG(X)PRT], catalyses the synthesis of the purine nucleoside monophosphates, IMP, GMP or XMP essential for DNA/RNA production. In protozoan parasites, such as Plasmodium, this is the only route available for their synthesis as they lack the de novo pathway which is present in human cells. Acyclic nucleoside phosphonates (ANPs), analogs of the purine nucleoside monophosphates, have been found to inhibit Plasmodium falciparum (Pf) HGXPRT and Plasmodium vivax (Pv) HGPRT with K(i) values as low as 100 nM. They arrest parasitemia in cell based assays with IC(50) values of the order of 1-10 μM. ANPs with phosphonoalkyl and phosphonoalkoxyalkyl moieties linking the purine base and phosphonate group were designed and synthesised to evaluate the influence of this linker on the potency and/or selectivity of the ANPs for the human and malarial enzymes. This data shows that variability in the linker, as well as the positioning of the oxygen in this linker, influences binding. The human enzyme binds the ANPs with K(i) values of 0.5 μM when the number of atoms in the linker was 5 or 6 atoms. However, the parasite enzymes have little affinity for such long chains unless oxygen is included in the three-position. In comparison, all three enzymes have little affinity for ANPs where the number of atoms linking the base and the phosphonate group is of the order of 2-3 atoms. The chemical nature of the purine base also effects the K(i) values. This data shows that both the linker and the purine base play an important role in the binding of the ANPs to these three enzymes.
650    _2
$a antimalarika $x chemická syntéza $x chemie $x farmakologie $7 D000962
650    _2
$a aktivace enzymů $x účinky léků $7 D004789
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a pentosyltransferasy $x antagonisté a inhibitory $x genetika $x metabolismus $7 D010430
650    _2
$a Plasmodium falciparum $x účinky léků $x enzymologie $7 D010963
650    _2
$a Plasmodium vivax $x účinky léků $x enzymologie $7 D010966
650    _2
$a protozoální proteiny $x antagonisté a inhibitory $x genetika $x metabolismus $7 D015800
650    _2
$a puriny $x chemická syntéza $x chemie $x farmakologie $7 D011687
650    _2
$a rekombinantní proteiny $x antagonisté a inhibitory $x genetika $x metabolismus $7 D011994
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hocková, Dana
700    1_
$a Holý, Antonín
700    1_
$a Dračínský, Martin
700    1_
$a Baszczyňski, Ondřej
700    1_
$a Jersey, John de
700    1_
$a Keough, Dianne T
700    1_
$a Guddat, Luke W
773    0_
$w MED00000769 $t Bioorganic & medicinal chemistry $x 1464-3391 $g Roč. 20, č. 2 (2012), s. 1076-89
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22178188 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121206115355 $b ABA008
999    __
$a ok $b bmc $g 946323 $s 781503
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 20 $c 2 $d 1076-89 $i 1464-3391 $m Bioorganic & medicinal chemistry $n Bioorg Med Chem $x MED00000769
LZP    __
$a Pubmed-20120815/12/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...